Hypocoagulability in Children With Decompensated Chronic Liver Disease and Sepsis: Assessment by Thromboelastography

Vignesh Vinayagamoorthy1, Anshu Srivastava1, Indranil Das2

  • 1From the Department of Paediatric Gastroenterology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India.

JPGN Reports
|August 21, 2023
PubMed

Insights

Children with decompensated chronic liver disease and infection often have abnormal coagulation, with thromboelastography (TEG) identifying hypocoagulable states and predicting poor outcomes. TEG is superior to INR and platelet counts for detecting bleeding risks.

Area of Science:

  • Pediatric Gastroenterology
  • Hepatology
  • Hematology

Background:

  • Decompensated chronic liver disease (DCLD) in children presents complex challenges, often complicated by infections.
  • Coagulation abnormalities are common in DCLD, potentially exacerbated by systemic infections.
  • Accurate assessment of coagulation status is crucial for managing these critically ill children.

Purpose of the Study:

  • To evaluate the coagulation status in children with DCLD and concurrent infection using thromboelastography (TEG).
  • To identify factors influencing coagulation abnormalities in this pediatric population.
  • To assess the predictive value of TEG parameters for bleeding and patient outcomes.

Main Methods:

  • Prospective study of 30 children with DCLD and infection.
  • Coagulation assessed using international normalized ratio (INR), platelet count, and TEG (R, K, α-angle, MA, CI, LY30) at admission and post-treatment.
  • Clinical data including systemic inflammatory response syndrome (SIRS), infection severity, bleeding events, and outcomes were collected.

Main Results:

  • At admission, 96.7% had prolonged INR, 80% thrombocytopenia, and 56.6% were hypocoagulable by TEG.
  • Hypocoagulability was more frequent in severe sepsis (81.1%) and persistent SIRS (100%).
  • Bleeding patients showed prolonged R-time and reduced MA/α-angle compared to non-bleeders; R-time ≥8.5 min predicted mortality (83% sensitivity, 100% specificity).

Conclusions:

  • Over half of children with DCLD and infection exhibit hypocoagulability detectable by TEG.
  • Severe sepsis and persistent SIRS significantly worsen coagulation status.
  • TEG provides superior insights into bleeding risk and predicts poor outcomes more effectively than traditional coagulation tests.
Abstract

Related Concept Videos

Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
989
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
10
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
751
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
14
Coagulation01:09

Coagulation

The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
7.1K
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
8.3K